Sharechat Logo

Daily ShareChat: Ryman Healthcare

By Jenny Ruth

Tuesday 30th November 2010

Text too small?
 Jenny Ruth

Ryman Healthcare's latest result highlights that the company's business model continues to deliver on the significant growth opportunity the growing elderly demographic offers, says Matt Henry, an analyst at Goldman Sachs & Partners.

The company maintains its strong defensive qualities which are proving resilient in a challenging housing market environment, Henry says.

Ryman reported a 36% rise in reported net profit to $52.3 million for the six months ended September with realised profit (excluding unrealised property valuation gains) up 25% to a record $36.1 million.

"We expect Ryman to maintain strong earnings growth through the medium term, driven by further development of new villages and maturing of existing assets," Henry says.

Ryman's accrued capital gains rose significantly to $160 million from $140 million at March 31, reflecting the strong price performance of its new villages.

"The size of future resale gains 'bucket' strengthens our confidence in the continued medium-term growth prospects for Ryman," he says.

Net debt rose only $12.5 million to $152.5 million in the latest six months, despite investing $65 million of cashflow spending on new assets and paying $17 million in dividends, "once again highlighting the exceptional capital efficiency of Ryman's business model."
Henry is forecasting full-year realised net profit will be $70.5 million, up from $61.4 million the previous year.


Recommendation: Buy.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Ryman's dip a buying opportunity as Australian expansion looms, First NZ says
Ryman Healthcare Limited
Ryman says first-quarter trading ahead of year earlier, meets company target
Ryman boosts FY profit 13 percent as fee income jumps, portfolio value climbs
Ryman Healthcare first-half profit rises 15 percent
Ryman's 1st Qtr ahead of last year; 28th village in Petone
Ryman Healthcare
Ryman may seek ASX listing as shares reach record high, profits rise
Ryman shares reach record high as profits rise
Ryman posts record FY profit, beats guidance, on strong demand for units